Identification of BXDC2 as a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer

SIMPLE SUMMARY: It remains unclear why chemotherapy is often ineffective in patients with bladder cancer. Meanwhile, we previously reported that male sex hormones (i.e., androgens) could considerably reduce the efficacy of cisplatin, an anti-cancer drug used as the first-line treatment against advan...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancers (Basel)
Hoofdauteurs: Jiang, Guiyang, Teramoto, Yuki, Goto, Takuro, Mizushima, Taichi, Inoue, Satoshi, Ide, Hiroki, Nagata, Yujiro, Kashiwagi, Eiji, Baras, Alexander S., Netto, George J., Yang, Zhiming, Miyamoto, Hiroshi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI 2021
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7956795/
https://ncbi.nlm.nih.gov/pubmed/33652650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13050975
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items